Attainment of therapeutic fluoride levels in serum without major side effects using a slow-release preparation of sodium fluoride in postmenopausal osteoporosis

2009 ◽  
Vol 1 (6) ◽  
pp. 563-571 ◽  
Author(s):  
Charles Y.C. Pak ◽  
Khashayar Sakhaee ◽  
Christopher Gallagher ◽  
Carol Parcel ◽  
Roy Peterson ◽  
...  
Keyword(s):  
Side Effects ◽  
Postmenopausal Osteoporosis ◽  
Sodium Fluoride ◽  
Slow Release ◽  
Release Preparation ◽  
Slow Release Preparation

Differences in side effects between a conventional carbamazepine preparation and a slow-release preparation of carbamazepine

1990 ◽  
Vol 6 (2) ◽  
pp. 134-140 ◽  
Author(s):  
Lennart I. Persson ◽  
Elinor Ben-Menachem ◽  
Erland Bengtsson ◽  
Esa Heinonen
Keyword(s):  
Side Effects ◽  
Slow Release ◽  
Release Preparation ◽  
Slow Release Preparation

Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis

2009 ◽  
Vol 11 (2) ◽  
pp. 160-168 ◽  
Author(s):  
Charles Y.C. Pak ◽  
Khashayar Sakhaee ◽  
Norman H. Bell ◽  
Angelo Licata ◽  
Conrad Johnston ◽  
...  
Keyword(s):  
Postmenopausal Osteoporosis ◽  
Sodium Fluoride ◽  
Slow Release ◽  
Controlled Trial

Study of adverse reactions to a once-weekly regimen of streptomycin plus a slow-release preparation of isoniazid in high dosage for six months

Tubercle ◽  
1976 ◽  
Vol 57 (2) ◽  
pp. 123-130 ◽  
Author(s):  
T. Santha ◽  
Wallace Fox ◽  
O. Nazareth ◽  
R. Prabhakar ◽  
S. Radhakrishna ◽  
...  
Keyword(s):  
Adverse Reactions ◽  
Slow Release ◽  
Release Preparation ◽  
Slow Release Preparation

Postscript: beta-blockers - the choice 1980, p 61 and 1981, p 20

1981 ◽  
Vol 19 (9) ◽  
pp. 36.2-36
Keyword(s):  
Slow Release ◽  
Beta Blockers ◽  
200Mg Tablet ◽  
Release Preparation ◽  
Slow Release Preparation

Metoprolol - A second slow-release preparation of metoprolol, Slow Lopresor (Geigy) has just been marketed. We had cited a study which indicated to us that one 200mg tablet of Slow Lopresor did not adequately block β-receptors for 24 hours (MJ Kendall et al, Eur J Clin Pharmacol 1980; 17: 87). The manufacturer has now shown us more recent evidence that one such tablet maintains some measurable β blockade over 24 hours, and is comparable with Betaloc SA.

Ventolin spandets (salbutamol)

1972 ◽  
Vol 10 (24) ◽  
pp. 94-95
Keyword(s):  
Single Dose ◽  
Slow Release ◽  
Salbutamol Sulphate ◽  
Release Preparation ◽  
Adrenergic Activity ◽  
Daily Dose ◽  
Slow Release Preparation

Salbutamol (Ventolin - A & H) is a sympathomimetic agent with mainly (β-adrenergic activity widely used as a bronchodilator. Ventolin Spandet has now been introduced as a slow-release preparation of oral salbutamol. The manufacturers make the specific claim that a single dose gives ‘predictable sustained relief of symptoms for up to 12 hours’, and recommend a daily dose of one. Spandet (salbutamol sulphate 8 mg) at bedtime and one after breakfast.

scholarly journals 5-Aminosalicylic Acid in a Slow-Release Preparation: Bioavailability, Plasma Level, and Excretion in Humans

1982 ◽  
Vol 83 (5) ◽  
pp. 1062-1070 ◽  
Author(s):  
S.N. Rasmussen ◽  
S. Bondesen ◽  
E.F. Hvidberg ◽  
S. Honoré Hansen ◽  
Vibeke Binder ◽  
...  
Keyword(s):  
Plasma Level ◽  
Slow Release ◽  
Aminosalicylic Acid ◽  
Release Preparation ◽  
Slow Release Preparation

Rectal bioavailability of lidocaine from a suppository and a slow release preparation in man

1979 ◽  
Vol 1 (1) ◽  
pp. 944-950 ◽  
Author(s):  
A. G. De Boer ◽  
D. D. Breimer ◽  
H. Mattie
Keyword(s):  
Slow Release ◽  
Release Preparation ◽  
Slow Release Preparation

Pharmacokinetic profile of a novel slow release preparation of molsidomine

1992 ◽  
Vol 43 (3) ◽  
pp. 273-276 ◽  
Author(s):  
S. Rietbrock ◽  
B. Keller-Stanislawski ◽  
P. Thürmann ◽  
D. Brockmeier
Keyword(s):  
Slow Release ◽  
Pharmacokinetic Profile ◽  
Release Preparation ◽  
Slow Release Preparation
Sign in / Sign up

Export Citation Format

Share Document